“…Moreover, Martins et al (21) reported that the regions of the body most frequently affected were the limbs (59.6%), followed by the face (34%). In addition, Murback et al (27) found that lesions were located in the lower limbs in 34%, in the face in 25.5%, and in the upper limbs in 19.1%, whereas Name et al (28) found that lesions were located in the lower limbs in 56.5%, in the upper limbs in 28.4%, and in the head in 13.6%. The amount of Glucantime® ampoules used did not differ according to the location of lesions at different sites.…”